Abbott uses jumbo euro debut to refi dollars
US healthcare company Abbott Laboratories debuted in the European corporate bond market on Monday, selling a €3.42bn triple-tranche deal. The proceeds of the jumbo deal were to repay the issuer’s outstanding deals in dollars.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: